MSB 7.73% $1.05 mesoblast limited

Atherys a stem cell stock is close to approvoal with their cell...

  1. 189 Posts.
    lightbulb Created with Sketch. 133
    Atherys a stem cell stock is close to approvoal with their cell therapy for ARDS acute respritory syndrome
    Approvoal could happen very fast in Japan with their partner Healios
    Cooronavirus causes ARDS and it will be the only useful therapy.Quick approvoal for this indication will be good for whole sector


  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.075(7.73%)
Mkt cap ! $1.107B
Open High Low Value Volume
99.5¢ $1.06 99.0¢ $3.334M 3.253M

Buyers (Bids)

No. Vol. Price($)
24 36676 $1.04
 

Sellers (Offers)

Price($) Vol. No.
$1.05 26489 20
View Market Depth
Last trade - 13.20pm 04/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.